NOVO-BENZYDAMINE - ORAL RINSE 1.5 MG
BENZYDAMINE HYDROCHLORIDE : 1.5 MG · DIN 02229799 · NOVOPHARM LIMITED
Health Canada status: CANCELLED POST MARKET
What is NOVO-BENZYDAMINE - ORAL RINSE?
NOVO-BENZYDAMINE - ORAL RINSE 1.5 MG contains BENZYDAMINE HYDROCHLORIDE : 1.5 MG. It is listed in the Health Canada Drug Product Database under DIN 02229799, held by NOVOPHARM LIMITED, supplied as MOUTHWASH/GARGLE ; LIQUID for ORAL ; BUCCAL administration. Health Canada currently lists it as cancelled post market, status dated 26-Oct-2015. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02229799 |
|---|---|
| Brand name | NOVO-BENZYDAMINE - ORAL RINSE |
| Generic / active ingredient | BENZYDAMINE HYDROCHLORIDE : 1.5 MG |
| Manufacturer | NOVOPHARM LIMITED |
| Strength | 1.5 MG |
| Dosage form | MOUTHWASH/GARGLE ; LIQUID |
| Route of administration | ORAL ; BUCCAL |
| Schedule | Prescription |
| ATC code | A01AD02 BENZYDAMINE |
| AHFS class | 52:28.00 ; 52:08.20 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 26-Oct-2015 |
| Original market date | 1997-02-06 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code A01AD02 BENZYDAMINE. 4 of 11 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ODAN-BENZYDAMINE | 0.15 % | MOUTHWASH/GARGLE | ODAN LABORATORIES LTD | MARKETED | DIN 02463105 |
| PHARIXIA | 0.15 % | MOUTHWASH/GARGLE | PENDOPHARM DIVISION OF PHARMASCIENCE INC | MARKETED | DIN 02229777 |
| PHARIXIA ALCOHOL FREE | 0.15 % | MOUTHWASH/GARGLE | PENDOPHARM DIVISION OF PHARMASCIENCE INC | MARKETED | DIN 02494434 |
| PMS-BENZYDAMINE | 0.15 % | MOUTHWASH/GARGLE | PHARMASCIENCE INC | MARKETED | DIN 02239537 |
| APO-BENZYDAMINE ORAL RINSE | 0.15 % | MOUTHWASH/GARGLE | APOTEX INC | CANCELLED POST MARKET | DIN 02239044 |
| NOVO-BENZYDAMINE | 1.5 MG | SOLUTION ; MOUTHWASH/GARGLE | NOVOPHARM LIMITED | CANCELLED POST MARKET | DIN 02310422 |
| NU-BENZYDAMINE ORAL RINSE | 0.15 % | LIQUID | NU-PHARM INC | CANCELLED (UNRETURNED ANNUAL) | DIN 02238794 |
| RATIO-BENZYDAMINE | 0.15 % | SOLUTION | RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED | CANCELLED POST MARKET | DIN 02230170 |
| SUN-BENZ - LIQ 0.15% | .15 % | LIQUID | SUN PHARMACEUTICAL INDUSTRIES INC. | CANCELLED POST MARKET | DIN 02226820 |
| TANTUM | 0.15 % | MOUTHWASH/GARGLE | BAUSCH HEALTH, CANADA INC. | DORMANT | DIN 01966065 |
Who else supplies BENZYDAMINE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. BENZYDAMINE appears in 67 registered pack listings across 6 markets, published on 4 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.